1,714 reports of this reaction
3.4% of all MYCOPHENOLIC ACID reports
#3 most reported adverse reaction
DRUG INEFFECTIVE is the #3 most commonly reported adverse reaction for MYCOPHENOLIC ACID, manufactured by Novartis Pharmaceuticals Corporation. There are 1,714 FDA adverse event reports linking MYCOPHENOLIC ACID to DRUG INEFFECTIVE. This represents approximately 3.4% of all 51,116 adverse event reports for this drug.
MYCOPHENOLIC ACID has an overall safety score of 88 out of 100. Patients taking MYCOPHENOLIC ACID who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among MYCOPHENOLIC ACID users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for MYCOPHENOLIC ACID:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 1,714 FDA reports for MYCOPHENOLIC ACID. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 3.4% of all adverse event reports for MYCOPHENOLIC ACID, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking MYCOPHENOLIC ACID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.